Pivotal bioequivalence trial of modified vs original REMOXY [oxycodone extended-release capsules].

Trial Profile

Pivotal bioequivalence trial of modified vs original REMOXY [oxycodone extended-release capsules].

Completed
Phase of Trial: Phase I

Latest Information Update: 11 May 2015

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Pharmacokinetics; Registrational
  • Sponsors Pfizer
  • Most Recent Events

    • 11 May 2015 Status changed from not yet recruiting to completed, as reported in a Pain Therapeutics media release.
    • 24 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top